Skip to main content
LLM 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Session XI: Evolving Options in MM

Friday, October 20, 2023
1:10 PM – 3:30 PM ET
Location: Metropolitan East

Talks in this session are supported by an educational grant from Karyopharm Therapeutics.

Presentations:

  • 1:10 PM – 1:15 PM ET
    Pre-Session Audience Survey
  • 1:15 PM – 1:25 PM ET
    Best Myeloma Abstract Presentation: Long-Term Follow-Up From the MajesTEC-1 Study of Teclistamab, a B-Cell Maturation Antigen (BCMA) × CD3 Bispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

    Abstract Presenter: María-Victoria Mateos, PhD – University Hospital of Salamanca

  • 1:25 PM – 1:40 PM ET
    The SASS-ARENA Foundation for Medical Research Award: Michaeli Award for Outstanding Contributions to Myeloma

    Presenter: Morton Coleman, MD – Weill Cornell Medicine

    Award Recipient : Angela Dispenzieri, MD – Mayo Clinic

  • 1:40 PM – 2:10 PM ET
    Award Lecture: POEMS- A Disease Model Biology and Treatment

    Speaker: Angela Dispenzieri, MD – Mayo Clinic

  • 2:10 PM – 2:30 PM ET
    Towards a Cure: How New Targets are being Exploited

    Speaker: Kenneth C. Anderson, MD – Harvard Medical School / Dana-Farber Cancer Institute

  • 2:30 PM – 2:50 PM ET
    CAR-T- When and How To Use? Is Any Particular Regimen Superior?

    Speaker: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center

  • 2:50 PM – 3:10 PM ET
    T Cell Engagers (Bispecifics) BCMA and Other Targets

    Speaker: Dan Vogl, MD, MSCE – University of Pennsylvania

  • 3:10 PM – 3:30 PM ET
    Panel Discussion and Post-Session Audience Survey

    Panelist: Kenneth C. Anderson, MD – Harvard Medical School / Dana-Farber Cancer Institute

    Panelist: Angela Dispenzieri, MD – Mayo Clinic

    Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center

    Panelist: Dan Vogl, MD, MSCE – University of Pennsylvania